Innate Pharma SA's market cap is currently €176.00M. The company's EPS TTM is €-0.421; its P/E ratio is ―; Innate Pharma SA is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is €-0.26. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	€ 51.90M	€ 49.64M	€ 12.11M	€ 56.83M	€ 68.97M
Gross Profit	€ -4.12M	€ -2.02M	€ -34.89M	€ 53.79M	€ 23.82M
Operating Income	€ -12.67M	€ -11.65M	€ -47.83M	€ -13.69M	€ -27.05M
EBITDA	€ -7.58M	€ -61.30M	€ -43.23M	€ 43.10M	€ -20.86M
Net Income	€ -7.57M	€ -99.10M	€ -59.14M	€ -70.75M	€ -20.96M
Balance Sheet
Cash & Short-Term Investments	€ 92.46M	€ 101.48M	€ 119.84M	€ 151.64M	€ 218.87M
Total Assets	€ 184.19M	€ 207.86M	€ 267.50M	€ 307.42M	€ 401.36M
Total Debt	€ 39.89M	€ 42.25M	€ 44.25M	€ 19.09M	€ 18.72M
Net Debt	€ -30.71M	€ -41.97M	€ -59.51M	€ -117.70M	€ -184.16M
Total Liabilities	€ 132.29M	€ 153.71M	€ 160.06M	€ 151.45M	€ 183.94M
Stockholders' Equity	€ 51.90M	€ 54.15M	€ 107.44M	€ 155.97M	€ 217.42M
Cash Flow
Free Cash Flow	€ -34.91M	€ -20.28M	€ -59.79M	€ -63.09M	€ -30.48M
Operating Cash Flow	€ -32.56M	€ -19.15M	€ -58.46M	€ -51.81M	€ 34.92M
Investing Cash Flow	€ 20.63M	€ 1.88M	€ -917.00K	€ -13.37M	€ -62.12M
Financing Cash Flow	€ -1.97M	€ -1.83M	€ 26.82M	€ -1.14M	€ 77.77M

Currency in EUR

Innate Pharma SA Earnings and Revenue History

Income Statement >

Innate Pharma SA Debt to Assets

Balance Sheet >

Innate Pharma SA Cash Flow

Cash Flow >

Innate Pharma SA Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing